umberto vitolo
机构: Hematology Consultant, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy
每年引用次数
引用次数
引用: 25,867
H-指数: 79
I10-指数 : 237
出版物: 882
Consensus conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian society of hematology
Vitolo Umberto , Barosi Giovanni , Fanti Stefano , AM Gianni
American journal of hematology 85 ( 2) 147 -155
9
2010
[Nutritional support in non-Hodgkin's lymphoma treated with polychemotherapy MACOP-B cycle].
Palmo A , Balzola F , Xompero G , Bertini M
Minerva gastroenterologica e dietologica 37 ( 2) 117
1991
Probability of cure in elderly Hodgkin's disease patients.
Vitolo U , Resegotti L , Pileri A , Bertini M
Haematologica 79 ( 1) 46 -54
37
1994
T acute lymphoblastic leukemia in ataxia-telangiectasia. Report of a case characterized by monoclonal antibodies.
Vitolo U , Marmont F , Paolino W , Caligaris Cappio F
Haematologica 69 ( 6) 695 -700
1
1984
Mitoxantrone, etoposide, cisplatin and dexamethasone (MEPD) as salvage chemotherapy in resistant non-Hodgkin's lymphoma.
Orsucci L , Ghio R , Cavallero G , Levis A
Haematologica 76 ( 1) 43 -45
9
1991
Role of thoracic computed tomography in the treatment plan of Hodgkin's disease.
Vitolo U , Bertini M , Garabello D , Orsucci L
Haematologica 75 ( 1) 64
1990
CHOP versus CNOP (N = mitoxantrone) in non-Hodgkin's lymphoma: an interim report comparing efficacy and toxicity.
Vitolo U , Resegotti L , Ferrini Pr , Bernasconi C
Haematologica 73 ( 3) 217 -222
23
1988
Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.
Salles G. Gopal AK , Schuster SJ , Fowler NH , Trotman J
Journal of Clinical Oncology 36 ( 23) 2405 -2405
96
2018
Role of Chemotherapy and Allografting in the Treatment of Acute Lymphoblastic Leukemia
Marmont F Giaccone L , Audisio E , Bruno B , Maffini E
Clin Lymphoma Myeloma Leuk 16 ( 2) 96 -103
3
2016
Using PET-CT in the Restaging of Primitive Mediastinal B-Cell Lymphoma (PMBCL) after chemotherapy: which criterion should we use?
Bisi G Giunta F , Zotta M , Menga M , Balma M
The Quarterly Journal Of Nuclear Medicine And Molecular Imaging 59 214 -9
3
2015
Core binding factor acute myeloid leukaemia and c-KIT mutations
LUDOVICA RIERA , FILIPPO MARMONT , DANIELA TOPPINO , CHIARA FRAIRIA
Oncology Reports 29 ( 5) 1867 -1872
20
2013
CHEMOSENSITIVITY IS THE STRONGEST PREDICTOR OF AUTOTRANSPLANT EFFICACY IN PATIENTS WITH RESISTANT, RELAPSING OR TRANSFORMED AGGRESSIVE NON-HODGKIN LYMPHOMA
S CORTELAZZO , F LUSSANA , A ROSSI , M GHIELMINI
HAEMATOLOGICA-PAVIA THEN ROMA- 84 ( 9; SUPP/1) 234 -234
1999
RISK-FACTORS T IN DIFFUSE LARGE CELL LYMPHOMA AT FIRST RELAPSE. A STUDY OF THE ITALIAN INTERGROUP FOR LYMPHOMAS
C GUGLIELMI , M MARTELLI , M FEDERICO , PL ZINZANI
HAEMATOLOGICA-PAVIA THEN ROMA- 84 ( 9; SUPP/1) 60 -60
1999
Results of a low aggressivity chemotherapy regimen (CVP
A LEVIS , L DEPAOLI , M BERTINI , B BOTTO
Haematologica 81 ( 5) 450 -456
1996
HIGH-DOSE SEQUENTIAL (HDS) REGIMEN AS SALVAGE TREATMENT FOR REFRACTORY/RELAPSED HODGKIN'S DISEASE: A MULTICENTRE EXPERIENCE
C Tarella , M Liberati , R Romano , P COSER
HAEMATOLOGICA-PAVIA THEN ROMA- 84 ( 9; SUPP/1) 59 -59
1
1999
HIGH-DOSE CHEMOTHERAPY AND PBPC AUTOGRAFTING INDUCE DURABLE MOLECULAR REMISSIONS IN FOLLICULAR, BUT NOT IN SMALL LYMPHOCYTIC AND MANTLE CELL LYMPHOMAS
P CORRADINI , M ASTOLFI , D CARACCIOLO , M LADETTO
HAEMATOLOGICA-PAVIA THEN ROMA- 84 ( 9; SUPP/1) 215 -215
1999
MegaCEOP: CYCLOPHOSPHAMIDE (CTX) AND EPIRUBICINE (EPI) ESCALATION IN AN INTENSIFIED SCHEME FOR THE TREATMENT OF POOR PROGNOSIS AGGRESSIVE NON HODGKIN'S LYMPHOMA (NHL)
B BOTTO , U VITOLO , G TODESCHINI , M PIZZUTI
HAEMATOLOGICA-PAVIA THEN ROMA- 84 ( 9; SUPP/1) 314 -314
1999
CONSERVATIVE THERAPY OF PRIMARY MALT GASTRIC LYMPHOMA
L ORSUCCI , B BOTTO , M BERTINI , C BOCCOMINI
HAEMATOLOGICA-PAVIA THEN ROMA- 84 ( 9; SUPP/1) 214 -214
1999
LONG TERM FU OF P-VEBEC, A TREATMENT SPECIFICALLY DEVISED FOR ELDERLY PATIENTS AFFECTED BY DIFFUSE LARGE CELL LYMPHOMAS (DLCL)
M BERTINI , R FREILONE , U VITOLO , B BOTTO
HAEMATOLOGICA-PAVIA THEN ROMA- 84 ( 9; SUPP/1) 322 -322
1999
FEASIBILITY AND PRELIMINARY RESULTS OF A HIGH DOSE CHEMOTHERAPY (HDC) WITH AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKIN'S LYMPHOMA (NHL) IN RELAPSE
U VITOLO , P PREGNO , M BERTINI , C BOCCOMINI
HAEMATOLOGICA-PAVIA THEN ROMA- 84 ( 9; SUPP/1) 234 -234
1999